Prudential Financial Inc Spring Works Therapeutics, Inc. Transaction History

Prudential Financial Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$36.5 - $52.5 $178,631 - $256,935	4,894 New	4,894 $240,000
Q2 2022 Aug 15, 2022	SELL	$18.36 - $60.07 $182,314 - $596,495	-9,930 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$48.97 - $65.46 $486,272 - $650,017	9,930 New	9,930 $560,000
Q4 2021 Feb 14, 2022	SELL	$53.3 - $75.84 $2.86 Million - $4.07 Million	-53,610 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$62.66 - $88.26 $1.53 Million - $2.15 Million	24,385 Added 83.44%	53,610 $3.4 Million
Q2 2021 Aug 16, 2021	BUY	$67.45 - $85.63 $1.24 Million - $1.57 Million	18,390 Added 169.73%	29,225 $2.41 Million
Q1 2021 May 12, 2021	SELL	$65.1 - $93.59 $477,248 - $686,108	-7,331 Reduced 40.36%	10,835 $797,000
Q1 2020 May 12, 2020	SELL	$20.44 - $41.21 $2,044 - $4,121	-100 Reduced 0.55%	18,166 $490,000
Q4 2019 Feb 11, 2020	BUY	$17.74 - $39.52 $324,038 - $721,872	18,266 New	18,266 $703,000

237

68.9M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.25B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.